BMC Medicine - 2019
Authors: Sigfrid, L., Perfect, C., Rojek, A., Longuere, K.S., Lipworth, S., Harriss, E., Lee, J., Salam, A., Carson, G., Goossens, H., Horby, P.
Abstract
The epidemiology of CNS infections in Europe is dynamic, requiring that clinicans have access to up-to-date clinical management guidelines (CMGs) to aid identification of emerging infections and for improving quality and a degree of standardisation in diagnostic and clinical management practices. This paper presents a systematic review of CMGs for community-acquired CNS infections in Europe.
Read the full paper here.
The epidemiology of CNS infections in Europe is dynamic, requiring that clinicians have access to up-to-date clinical management guidelines (CMGs) to aid identification of emerging infections and for improvingquality and a degree of standardisation in diagnostic and clinical management practices. This paper presents asystematic review of CMGs for community-acquired CNS infections in Europe.
TheThe epidemiology of CNS infections in Europe is dynamic, requiring that clinicians have access to The epidemiology of CNS infections in Europe is dynamic, requiring that clinicians have access to up-to-date clinical management guidelines (CMGs) to aid identification of emerging infections and for improvingquality and a degree of standardisation in diagnostic and clinical management practices. This paper presents asystematic review of CMGs for community-acquired CNS infections in Europe.up-to-date clinical management guidelines (CMGs) to aid identification of emerging infections and for improvingquality and a degree of standardisation in diagnostic and clinical management practices. This paper presents asystematic review of CMGs for community-acquired CNS infections in Europe. epidemiology of CNS infections in Europe is dynamic, requiring that clinicians have access to up-to-date clinical management guidelines (CMGs) to aid identification of emerging infections and for improvingquality and a degree of standardisation in diagnostic and clinical management practices. This paper presents asystematic review of CMGs for community-acquired CNS infections in Europe.